KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Income from Non-Controlling Interests (2023 - 2025)

Boston Scientific (BSX) has disclosed Income from Non-Controlling Interests for 3 consecutive years, with -$2.0 million as the latest value for Q4 2025.

  • Quarterly Income from Non-Controlling Interests rose 50.0% to -$2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$6.0 million through Dec 2025, up 14.29% year-over-year, with the annual reading at -$6.0 million for FY2025, 25.0% up from the prior year.
  • Income from Non-Controlling Interests hit -$2.0 million in Q4 2025 for Boston Scientific, roughly flat from -$2.0 million in the prior quarter.
  • In the past five years, Income from Non-Controlling Interests ranged from a high of -$1.0 million in Q4 2023 to a low of -$4.0 million in Q4 2024.
  • Historically, Income from Non-Controlling Interests has averaged -$2.0 million across 3 years, with a median of -$2.0 million in 2024.
  • Biggest five-year swings in Income from Non-Controlling Interests: plummeted 300.0% in 2024 and later soared 50.0% in 2025.
  • Year by year, Income from Non-Controlling Interests stood at -$1.0 million in 2023, then tumbled by 300.0% to -$4.0 million in 2024, then skyrocketed by 50.0% to -$2.0 million in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for BSX at -$2.0 million in Q4 2025, -$2.0 million in Q2 2025, and -$2.0 million in Q1 2025.